The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SNGX · Healthcare · No moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | PGEN | ICCC | SNGX | SCNX |
|---|---|---|---|---|
| Moat Score (0–100) | 33 (highest) | 33 (highest) | 33 (highest) | 33 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 15 | 54 (highest) | 27 | 20 |
| Pricing power | 99 (highest) | 54 | 7 | 69 |
| Returns on capital | 0 | 0 | — | 4 (highest) |
| Balance-sheet safety | 28 | 42 | 55 (highest) | 28 |
| Capital allocation | 24 | 16 | 44 (highest) | 44 (highest) |
| No price data | No price data | No price data | No price data | |
| Market cap | $1.9B | $99.8M | $3.7M | $15M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |